Global Live Attenuated Vaccine Detailed Analysis Report 2017-2022

August 2017 | 104 pages | ID: GDE925D8268EN
Detailed-Analysis Research (DAR)

Abstracts

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Live Attenuated Vaccine industry.

This report splits Live Attenuated Vaccine market By End User, By Disease Indication, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022.

This report focuses Global market, it covers details as following:

Major Companies

• Astellas Pharma (Japan)
• CSL Limited (Australia)
• Emergent BioSolutions (U.S.)
• GlaxoSmithKline (U.K.)
• Johnson & Johnson (U.S.)
• MedImmune (U.S.)
• Merck & Co (U.S.)
• Pfizer (U.S.)
• Sanofi Pasteur (France)
• Serum Institute of India Pvt (India)

Main Regions

• North America
• United States
• Canada
• Latin America
• Mexico
• Brazil
• Argentina
• Others
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherland
• Others
• Asia & Pacific
• China
• Japan
• India
• Korea
• Australia
• Southeast Asia
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Others
• Africa & Middle East
• South Africa
• Egypt
• Turkey
• Saudi Arabia
• Iran
• Others

Main Product Type

Live Attenuated Vaccine Market, by End User

• Pediatrics
• Adults

Live Attenuated Vaccine Market, by Disease Indication

• Pneumococcal
• Influenza
• HPV
• Hepatitis
• Rotavirus

Main Applications

• Hospital
• Medical Center
• Others

Contents

Global Live Attenuated Vaccine Detailed Analysis Report 2017-2022

CHAPTER ONE LIVE ATTENUATED VACCINE MARKET OVERVIEW

1.1 Global Live Attenuated Vaccine Market Sales Volume Revenue and Price 2012-2022
1.2 Live Attenuated Vaccine, By End User 2012-2022
  1.2.1 Global Live Attenuated Vaccine Sales Market Share by End User 2012-2022
  1.2.2 Global Live Attenuated Vaccine Revenue Market Share by End User 2012-2022
  1.2.3 Global Live Attenuated Vaccine Price by End User 2012-2022
  1.2.4 Pediatrics
  1.2.5 Adults
1.3 Live Attenuated Vaccine, by Disease Indication 2012-2022
  1.3.1 Global Live Attenuated Vaccine Sales Market Share by Disease Indication 2012-2022
  1.3.2 Global Live Attenuated Vaccine Revenue Market Share by Disease Indication 2012-2022
  1.3.3 Global Live Attenuated Vaccine Price by Disease Indication 2012-2022
  1.3.4 Pneumococcal
  1.3.5 Influenza
  1.3.6 HPV
  1.3.7 Hepatitis
  1.3.8 Rotavirus

CHAPTER TWO LIVE ATTENUATED VACCINE BY REGIONS 2012-2017

2.1 Global Live Attenuated Vaccine Sales Market Share by Regions 2012-2017
2.2 Global Live Attenuated Vaccine Revenue Market Share by Regions 2012-2017
2.3 Global Live Attenuated Vaccine Price by Regions 2012-2017
2.4 North America
  2.4.1 United States
  2.4.2 Canada
2.5 Latin America
  2.5.1 Mexico
  2.5.2 Brazil
  2.5.3 Argentina
  2.5.4 Others in Latin America
2.6 Europe
  2.6.1 Germany
  2.6.2 United Kingdom
  2.6.3 France
  2.6.4 Italy
  2.6.5 Spain
  2.6.6 Russia
  2.6.7 Netherland
  2.6.8 Others in Europe
2.7 Asia & Pacific
  2.7.1 China
  2.7.2 Japan
  2.7.3 India
  2.7.4 Korea
  2.7.5 Australia
  2.7.6 Southeast Asia
    2.7.6.1 Indonesia
    2.7.6.2 Thailand
    2.7.6.3 Philippines
    2.7.6.4 Vietnam
    2.7.6.5 Singapore
    2.7.6.6 Malaysia
    2.7.6.7 Others in Southeast Asia
2.8 Africa & Middle East
  2.8.1 South Africa
  2.8.2 Egypt
  2.8.3 Turkey
  2.8.4 Saudi Arabia
  2.8.5 Iran
  2.8.6 Others in Africa & Middle East

CHAPTER THREE LIVE ATTENUATED VACCINE BY PLAYERS 2012-2017

3.1 Global Live Attenuated Vaccine Sales Volume Market Share by Players 2012-2017
3.2 Global Live Attenuated Vaccine Revenue Share by Players 2012-2017
3.3 Global Top Players Live Attenuated Vaccine Key Product Model and Market Performance
3.4 Global Top Players Live Attenuated Vaccine Key Target Consumers and Market Performance

CHAPTER FOUR LIVE ATTENUATED VACCINE BY CONSUMER 2012-2017

4.1 Global Live Attenuated Vaccine Sales Market Share by Consumer 2012-2017
4.2 Hospital
4.3 Medical Center
4.4 Others
4.5 Consuming Habit and Preference

CHAPTER FIVE GLOBAL TOP PLAYERS PROFILE

5.1 Astellas Pharma (Japan)
  5.1.1 Astellas Pharma (Japan) Company Details and Competitors
  5.1.2 Astellas Pharma (Japan) Key Live Attenuated Vaccine Models and Performance
  5.1.3 Astellas Pharma (Japan) Live Attenuated Vaccine Business SWOT Analysis and Forecast
  5.1.4 Astellas Pharma (Japan) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.2 CSL Limited (Australia)
  5.2.1 CSL Limited (Australia) Company Details and Competitors
  5.2.2 CSL Limited (Australia) Key Live Attenuated Vaccine Models and Performance
  5.2.3 CSL Limited (Australia) Live Attenuated Vaccine Business SWOT Analysis and Forecast
  5.2.4 CSL Limited (Australia) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.3 Emergent BioSolutions (U.S.)
  5.3.1 Emergent BioSolutions (U.S.) Company Details and Competitors
  5.3.2 Emergent BioSolutions (U.S.) Key Live Attenuated Vaccine Models and Performance
  5.3.3 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
  5.3.4 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.4 GlaxoSmithKline (U.K.)
  5.4.1 GlaxoSmithKline (U.K.) Company Details and Competitors
  5.4.2 GlaxoSmithKline (U.K.) Key Live Attenuated Vaccine Models and Performance
  5.4.3 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
  5.4.4 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.5 Johnson & Johnson (U.S.)
  5.5.1 Johnson & Johnson (U.S.) Company Details and Competitors
  5.5.2 Johnson & Johnson (U.S.) Key Live Attenuated Vaccine Models and Performance
  5.5.3 Johnson & Johnson (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
  5.5.4 Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.6 MedImmune (U.S.)
  5.6.1 MedImmune (U.S.) Company Details and Competitors
  5.6.2 MedImmune (U.S.) Key Live Attenuated Vaccine Models and Performance
  5.6.3 MedImmune (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
  5.6.4 MedImmune (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.7 Merck & Co (U.S.)
  5.7.1 Merck & Co (U.S.) Company Details and Competitors
  5.7.2 Merck & Co (U.S.) Key Live Attenuated Vaccine Models and Performance
  5.7.3 Merck & Co (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
  5.7.4 Merck & Co (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.8 Pfizer (U.S.)
  5.8.1 Pfizer (U.S.) Company Details and Competitors
  5.8.2 Pfizer (U.S.) Key Live Attenuated Vaccine Models and Performance
  5.8.3 Pfizer (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
  5.8.4 Pfizer (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.9 Sanofi Pasteur (France)
  5.9.1 Sanofi Pasteur (France) Company Details and Competitors
  5.9.2 Sanofi Pasteur (France) Key Live Attenuated Vaccine Models and Performance
  5.9.3 Sanofi Pasteur (France) Live Attenuated Vaccine Business SWOT Analysis and Forecast
  5.9.4 Sanofi Pasteur (France) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.10 Serum Institute of India Pvt (India)
  5.10.1 Serum Institute of India Pvt (India) Company Details and Competitors
  5.10.2 Serum Institute of India Pvt (India) Key Live Attenuated Vaccine Models and Performance
  5.10.3 Serum Institute of India Pvt (India) Live Attenuated Vaccine Business SWOT Analysis and Forecast
  5.10.4 Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin

CHAPTER SIX INDUSTRY CHAIN AND SUPPLY CHAIN

6.1 Live Attenuated Vaccine Industry Chain Structure
  6.1.1 R&D
  6.1.2 Raw Materials (Components)
  6.1.3 Manufacturing Plants
  6.1.4 Regional Trading (Import Export and Local Sales)
  6.1.5 Online Sales Channel
  6.1.6 Offline Channel
  6.1.7 End Users
6.2 Live Attenuated Vaccine Manufacturing
  6.2.1 Key Components
  6.2.2 Assembly Manufacturing
6.3 Consumer Preference
6.4 Behavioral Habits
6.5 Marketing Environment

CHAPTER SEVEN GLOBAL LIVE ATTENUATED VACCINE MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

7.1 Global Live Attenuated Vaccine Sales (Million Units), Revenue (Million USD) Forecast (2017-2022)
7.2 Global Live Attenuated Vaccine Sales (Million Units) Forecast by Regions (2017-2022)
7.3 Global Live Attenuated Vaccine Sales (Million Units) Forecast by Application (2017-2022)
7.4 Global Live Attenuated Vaccine Sales (Million Units) Forecast by End User (2017-2022)
7.5 Global Live Attenuated Vaccine Sales (Million Units) Forecast by Disease Indication (2017-2022)

CHAPTER EIGHT DEVELOPMENT TREND AND RESEARCH CONCLUSION

8.1 Development Trend
8.2 Research Conclusion

CHAPTER NINE METHODOLOGY AND DATA SOURCE

9.1 Methodology/Research Approach
  9.1.1 Research Programs/Design
  9.1.2 Market Size Estimation
  9.1.3 Market Breakdown and Data Triangulation
9.2 Data Source
  9.2.1 Secondary Sources
  9.2.2 Primary Sources
9.3 Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Table Global Live Attenuated Vaccine Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table Global Live Attenuated Vaccine Sales (K Pcs) by End User (2012-2017)
Table Global Live Attenuated Vaccine Sales Market Share by End User (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by End User in 2016
Table Global Live Attenuated Vaccine Revenue (Million USD) by End User (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by End User (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by End User in 2016
Table Global Live Attenuated Vaccine Price (USD/Pcs) by End User (2012-2017)
Table Top Players of Pediatrics Live Attenuated Vaccine Products List
Figure Global Pediatrics Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Players of Adults Live Attenuated Vaccine Products List
Figure Global Adults Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Global Live Attenuated Vaccine Sales (K Pcs) by Disease Indication (2012-2017)
Table Global Live Attenuated Vaccine Sales Market Share by Disease Indication (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by Disease Indication in 2016
Table Global Live Attenuated Vaccine Revenue (Million USD) by Disease Indication (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by Disease Indication (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by Disease Indication in 2016
Table Global Live Attenuated Vaccine Price (USD/Pcs) by Disease Indication (2012-2017)
Table Top Players of Pneumococcal Live Attenuated Vaccine Products List
Figure Global Pneumococcal Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Players of Influenza Live Attenuated Vaccine Products List
Figure Global Influenza Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Players of HPV Live Attenuated Vaccine Products List
Figure Global HPV Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Players of Hepatitis Live Attenuated Vaccine Products List
Figure Global Hepatitis Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Players of Rotavirus Live Attenuated Vaccine Products List
Figure Global Rotavirus Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Global Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Global Live Attenuated Vaccine Sales Share by Regions (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by Regions in 2016
Figure Global Live Attenuated Vaccine Sales Market Share by Regions in 2017
Table Global Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by Regions (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by Regions in 2016
Figure Global Live Attenuated Vaccine Revenue Market Share by Regions in 2017
Table Global Live Attenuated Vaccine Price (USD/Pcs) by Regions (2012-2017)
Table North America Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table North America Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table North America Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
Figure North America Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Latin America Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Latin America Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Latin America Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
Figure Latin America Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Europe Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Europe Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Europe Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
Figure Europe Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Asia & Pacific Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Asia & Pacific Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Asia & Pacific Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
Figure Asia & Pacific Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
Figure Southeast Asia Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Africa & Middle East Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Africa & Middle East Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Africa & Middle East Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
Figure Africa & Middle East Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Global Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
Table Global Live Attenuated Vaccine Sales Volume Market Share by Key Players (2012-2017)
Figure Global Live Attenuated Vaccine Sales Volume Market Share by Key Players 2016
Figure Global Live Attenuated Vaccine Sales Volume Market Share by Key Players 2017
Table Global Live Attenuated Vaccine Revenue (Million USD) by Key Players (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by Key Players (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by Key Players 2016
Figure Global Live Attenuated Vaccine Revenue Market Share by Key Players 2017
Table Global Top Players Key Product Model and Market Performance
Table Global Top Players Key Target Consumers and Market Performance
Table Global Live Attenuated Vaccine Sales (K Pcs) by Consumer (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by Consumer (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by Consumer in 2016
Figure Global Hospital Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Medical Center Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Others Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Astellas Pharma (Japan) Company Details and Competitors
Table Astellas Pharma (Japan) Key Live Attenuated Vaccine Models and Performance
Table Astellas Pharma (Japan) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Astellas Pharma (Japan) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2022)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2022)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2022)
Table CSL Limited (Australia) Company Details and Competitors
Table CSL Limited (Australia) Key Live Attenuated Vaccine Models and Performance
Table CSL Limited (Australia) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table CSL Limited (Australia) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
Figure CSL Limited (Australia) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2022)
Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2022)
Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
Figure CSL Limited (Australia) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2022)
Table Emergent BioSolutions (U.S.) Company Details and Competitors
Table Emergent BioSolutions (U.S.) Key Live Attenuated Vaccine Models and Performance
Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2022)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2022)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2022)
Table GlaxoSmithKline (U.K.) Company Details and Competitors
Table GlaxoSmithKline (U.K.) Key Live Attenuated Vaccine Models and Performance
Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2022)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2022)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2022)
Table Johnson & Johnson (U.S.) Company Details and Competitors
Table Johnson & Johnson (U.S.) Key Live Attenuated Vaccine Models and Performance
Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2022)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2022)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2022)
Table MedImmune (U.S.) Company Details and Competitors
Table MedImmune (U.S.) Key Live Attenuated Vaccine Models and Performance
Table MedImmune (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table MedImmune (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
Figure MedImmune (U.S.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2022)
Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2022)
Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
Figure MedImmune (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2022)
Table Merck & Co (U.S.) Company Details and Competitors
Table Merck & Co (U.S.) Key Live Attenuated Vaccine Models and Performance
Table Merck & Co (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Merck & Co (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2022)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2022)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2022)
Table Pfizer (U.S.) Company Details and Competitors
Table Pfizer (U.S.) Key Live Attenuated Vaccine Models and Performance
Table Pfizer (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Pfizer (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
Figure Pfizer (U.S.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2022)
Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2022)
Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
Figure Pfizer (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2022)
Table Sanofi Pasteur (France) Company Details and Competitors
Table Sanofi Pasteur (France) Key Live Attenuated Vaccine Models and Performance
Table Sanofi Pasteur (France) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Sanofi Pasteur (France) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2022)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2022)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2022)
Table Serum Institute of India Pvt (India) Company Details and Competitors
Table Serum Institute of India Pvt (India) Key Live Attenuated Vaccine Models and Performance
Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2022)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2022)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2022)
Figure Global Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Live Attenuated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
Table Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions in 2022
Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Application in 2022
Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
Figure Global Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by End User in 2022
Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
Figure Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Disease Indication in 2022